157 related articles for article (PubMed ID: 22676198)
1. CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene.
Skierka JM; Walker DL; Peterson SE; O'Kane DJ; Black JL
Pharmacogenomics; 2012 Jun; 13(8):951-4. PubMed ID: 22676198
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs.
Savino M; Seripa D; Gallo AP; Garrubba M; D'Onofrio G; Bizzarro A; Paroni G; Paris F; Mecocci P; Masullo C; Pilotto A; Santini SA
Clin Lab; 2011; 57(11-12):887-93. PubMed ID: 22239018
[TBL] [Abstract][Full Text] [Related]
3. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
[TBL] [Abstract][Full Text] [Related]
4. CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification: Resolution of a Complex Genotype and a Discordant Genotype Involving the CYP2D6*59 Allele.
Gaedigk A; Riffel AK; Leeder JS
J Mol Diagn; 2015 Nov; 17(6):740-8. PubMed ID: 26335396
[TBL] [Abstract][Full Text] [Related]
5. Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
Numanagić I; Malikić S; Pratt VM; Skaar TC; Flockhart DA; Sahinalp SC
Bioinformatics; 2015 Jun; 31(12):i27-34. PubMed ID: 26072492
[TBL] [Abstract][Full Text] [Related]
6. Correlation between cytochrome P-450 CYP2D6 (CYP2D6) genotype and phenotype.
Chen SQ; Wedlund PJ
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):585-8. PubMed ID: 10678117
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians.
Al-Dosari MS; Al-Jenoobi FI; Alkharfy KM; Alghamdi AM; Bagulb KM; Parvez MK; Al-Mohizea AM; Al-Muhsen S; Halwani R
Environ Toxicol Pharmacol; 2013 Nov; 36(3):1063-7. PubMed ID: 24121619
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 CYP2D6.
Wolf CR; Smith G
IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
10. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
11. Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication.
Ledesma MC; Agúndez JA
Clin Chem; 2005 Jun; 51(6):939-43. PubMed ID: 15817819
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.
Gaedigk A; Hernandez J; García-Solaesa V; Sánchez S; Isidoro-García M
Pharmacogenomics; 2011 Nov; 12(11):1617-22. PubMed ID: 22044417
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cytochrome P450 2D6 alleles using the Invader system.
Nevilie M; Selzer R; Aizenstein B; Maguire M; Hogan K; Walton R; Welsh K; Neri B; de Arruda M
Biotechniques; 2002 Jun; Suppl():34-8, 40-3. PubMed ID: 12083395
[TBL] [Abstract][Full Text] [Related]
14. Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment.
Park IH; Ro J; Park S; Lim HS; Lee KS; Kang HS; Jung SY; Lee S
Breast Cancer Res Treat; 2012 Jan; 131(2):455-61. PubMed ID: 21437611
[TBL] [Abstract][Full Text] [Related]
15. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres M; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
[TBL] [Abstract][Full Text] [Related]
16. Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.
Karle J; Bolbrinker J; Vogl S; Kreutz R; Denkert C; Eucker J; Wischnewsky M; Possinger K; Regierer AC
Breast Cancer Res Treat; 2013 Jun; 139(2):553-60. PubMed ID: 23686417
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations of human CYP2D6 in the Chinese Han population.
Qian JC; Xu XM; Hu GX; Dai DP; Xu RA; Hu LM; Li FH; Zhang XH; Yang JF; Cai JP
Pharmacogenomics; 2013 Nov; 14(14):1731-43. PubMed ID: 24192122
[TBL] [Abstract][Full Text] [Related]
18. Patients with difficult-to-treat depression do not exhibit an increased frequency of CYP2D6 allele duplication.
Háber A; Rideg O; Osváth P; Fekete S; Szücs F; Fittler A; Kovács GL; Miseta A; Botz L
Pharmacopsychiatry; 2013 Jun; 46(4):156-60. PubMed ID: 23737191
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
[TBL] [Abstract][Full Text] [Related]
20. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
Buzková H; Pechandová K; Slanar O; Perlík F
Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
